Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.
about
T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-AntitrypsinAcute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threatsMechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetesExpanding the clinical indications for α(1)-antitrypsin therapyDanger Signals and Graft-versus-host Disease: Current Understanding and Future PerspectivesIL-32-induced Inflammatory Cytokines Are Selectively Suppressed by α1-antitrypsin in Mouse Bone Marrow Cells.α-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.Advances in understanding the pathogenesis of graft-versus-host disease.Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantationEffect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes.Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.Novel insights into the biology of interleukin-32.Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.Immune-modulating effects of alpha-1 antitrypsin.Next generation treatment of acute graft-versus-host disease.Immune Homeostatic Macrophages Programmed by the Bacterial Surface Protein NhhA Potentiate Nasopharyngeal Carriage of Neisseria meningitidis.Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update.Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.α-Linoleic acid enhances the capacity of α-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1β in human blood neutrophilsIL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.New and emerging therapies for acute and chronic graft versus host disease.TAK1 inhibition ameliorates survival from graft-versus-host disease in an allogeneic murine marrow transplantation model.Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.Novel therapeutic uses of alpha-1 antitrypsin: a window to the future.
P2860
Q26829272-2597AC74-167B-4B40-B7F0-D3EF35AE19FFQ26858837-1B9993E6-CFEF-4ED1-9209-15A0B9C91379Q26861561-3D6B752C-B49C-4112-95C9-10BA278EC24AQ27000764-DA4A1EE8-2A73-4450-B0E1-15E0E48C4E55Q28075204-053B0BD1-EB78-46BA-9B1B-990A251F0BD4Q33611313-F3E6EB11-97DA-4B08-AF33-92B54796DE9CQ34431458-BAAA9A3B-BD56-4185-A2D9-F4DE8A5EFD89Q35022269-3D945B9B-0BEE-413C-A918-40176BA5CBFDQ35179622-530A33DB-FB63-4C4C-86A6-5553812A81E5Q35673668-B7241642-7A7C-45B6-AC0E-FA8097C18E80Q35971439-36803FD8-210A-4939-A1A1-DD36BFD04484Q36305350-AE517D17-CCBD-4541-82E4-1DFF0EBD4CDEQ36885672-AED1506B-0A47-41B5-966D-730B8378F203Q37173117-BC01BC60-21A4-4BA7-9EB9-A94A15398AE1Q38086768-3600B9F3-2D7B-4C82-80F9-3CED533F12EDQ38132090-780E4134-97EF-41E0-A450-00AC77C6C098Q38214040-55F96BBC-5748-4AB1-8B37-026D19BA9CAEQ38221028-DD57B9C6-965C-4AD3-A647-EFB2247CBDF6Q38404143-0D0F443B-F4C2-44EA-80E5-D28C9B88AC44Q38643507-A4D12BB8-3611-4CF3-80B4-720F31A109F7Q38743931-AFE7DB51-9D8B-4B18-9ADE-885FE6867C25Q39565971-D6E90AAD-64B9-4EA9-8D02-0361115FB2E9Q41945018-8580BC85-1B5B-4A1C-8157-9FE203244DB5Q49238507-7039B2BD-75AF-4CB6-B297-1DAFC21A54BDQ50062411-19204691-C851-4A65-8042-1A9C58C8A098Q51465416-999D2F71-8A38-462A-A013-5A9C9488D1D7Q51534901-ED5E0BC8-3BFE-42A5-A337-2ABAB15EA4C1
P2860
Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhibition of IL-32 activation ...... marrow transplantation model.
@ast
Inhibition of IL-32 activation ...... marrow transplantation model.
@en
type
label
Inhibition of IL-32 activation ...... marrow transplantation model.
@ast
Inhibition of IL-32 activation ...... marrow transplantation model.
@en
prefLabel
Inhibition of IL-32 activation ...... marrow transplantation model.
@ast
Inhibition of IL-32 activation ...... marrow transplantation model.
@en
P2093
P2860
P1433
P1476
Inhibition of IL-32 activation ...... marrow transplantation model.
@en
P2093
A Mario Marcondes
George E Sale
John A Hansen
Julia Kabacka
Laura Tabellini
Matthias Bartenstein
P2860
P304
P356
10.1182/BLOOD-2011-07-365247
P407
P577
2011-09-06T00:00:00Z